Pier 88 Investment Partners’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-60,000	Closed	-$150K	–	93
2022 Q4	$150K	Buy	60,000 +32,300	+117%	+$80.8K	0.04%	82
2022 Q3	$117K	Buy	27,700 +27,000	+3,857%	+$114K	0.03%	91
2022 Q2	$2K	Sell	700 -135,630	-99%	-$388K	﹤0.01%	102
2022 Q1	$780K	Buy	136,330 +37,500	+38%	+$215K	0.28%	65
2021 Q4	$902K	Buy	98,830 +51,900	+111%	+$474K	0.19%	78
2021 Q3	$502K	Buy	46,930 +3,320	+8%	+$35.5K	0.15%	91
2021 Q2	$677K	Hold	43,610	–	–	0.19%	89
2021 Q1	$707K	Sell	43,610 -4,800	-10%	-$77.8K	0.24%	78
2020 Q4	$1.03M	Buy	48,410 +10,730	+28%	+$227K	0.33%	62
2020 Q3	$558K	Sell	37,680 -20,146	-35%	-$298K	0.17%	91
2020 Q2	$850K	Buy	57,826 +12,356	+27%	+$182K	0.24%	82
2020 Q1	$534K	Buy	45,470 +16,600	+57%	+$195K	0.19%	73
2019 Q4	$678K	Sell	28,870 -16,500	-36%	-$387K	0.27%	52
2019 Q3	$839K	Buy	45,370 +10,785	+31%	+$199K	0.33%	50
2019 Q2	$643K	Sell	34,585 -790	-2%	-$14.7K	0.27%	63
2019 Q1	$865K	Buy	35,375 +13,870	+64%	+$339K	0.4%	44
2018 Q4	$558K	Buy	21,505 +4,400	+26%	+$114K	0.28%	50
2018 Q3	$541K	Buy	17,105 +5,490	+47%	+$174K	0.24%	59
2018 Q2	$451K	Buy	+11,615	New	+$451K	0.21%	63